Alyssa S. Tilhou, MD, PhD

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Tilhou is a family physician, addiction specialist and health services researcher in the Department of Family Medicine at Boston Medical Center. She is also the department's Research Director. Her research focuses on access and utilization of primary care and substance use services in low-income populations. Dr. Tilhou completed her medical education and doctorate in Population Health Sciences at the University of Texas Medical Branch, residency in family medicine at the Mountain Area Health Education Center in Asheville, NC, and a fellowship in Addiction Medicine at the University of Wisconsin. She is supported by a K08 from the National Institute on Drug Abuse. Other recent funding includes a BU CTSI pilot award to study disparities in buprenorphine quality indicators among BMC patients and a contract with the Wisconsin Department of Health Services to evaluate the impact of a Section 1115 waiver on health care utilization and outcomes among Medicaid beneficiaries.

Publications

  • Published 4/22/2025

    Tilhou AS, Grucza RA, Xu KY. Substance-induced mental disorders and discontinuation of medication for opioid use disorder. Drug Alcohol Depend. 2025 Apr 22; 272:112685. PMID: 40319789.

    Read at: PubMed

  • Published 2/28/2025

    Tilhou AS, Gasman S, Wang J, Standish K, White LF, Cogan A, Devlin M, Larochelle M, Adams WG. Assessing inequities in buprenorphine treatment across the care cascade. Drug Alcohol Depend. 2025 May 01; 270:112636. PMID: 40043350.

    Read at: PubMed

  • Published 5/17/2024

    Tilhou A, Baldwin M, Alves J. No Time to Wait: Leveraging Primary Care to Treat Stimulant Use Disorder. Am J Prev Med. 2024 Sep; 67(3):464-469. PMID: 38762205.

    Read at: PubMed

  • Published 4/1/2024

    Tilhou AS, Dague L, Chachlani P, Burns M. Can telehealth expansion boost health care utilization specifically for patients with substance use disorders relative to patients with other types of chronic disease? PLoS One. 2024; 19(4):e0299397. PMID: 38557607.

    Read at: PubMed

  • Published 3/17/2024

    Tilhou AS, Burns M, Chachlani P, Chen Y, Dague L. How Does Telehealth Expansion Change Access to Healthcare for Patients With Different Types of Substance Use Disorders? Subst Use Addctn J. 2024 Jul; 45(3):473-485. PMID: 38494728.

    Read at: PubMed

Education

  • Harvard University, AB
  • University of Texas Medical Branch, MD/PhD